Production of antibodies and to medical uses involving antibodies
AssigneeThe Binding Site Group Limited
InventorArthur Randell Bradwell
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Binding Site Group Limited
InventorArthur Randell Bradwell
Estimating the term…
A method of making antibodies to a selected part P of an immunoglobulin molecule ZP, Z comprising the non-selected part of ZP, P being the selected part of ZP which comprises a hidden epitope of the light chain, said method comprises tolerizing the source of antibodies, by administering to the source a compound containing the non-selected part Z or a part of Z and administering antibodies to the non-selected part Z or a part of Z; wherein these administered antibodies are specific to an Fc region of ZP; and immunizing the source of antibodies with part of ZP having the selected part P exposed; and wherein Z comprises non-hidden epitopes of said immunoglobulin molecule, and wherein said compound containing the non-selected part of said molecule comprises a whole immunoglobulin, and wherein immunizing the source of antibodies with part of ZP comprises immunizing with free light chain.
A method of producing antibodies that are specific to hidden epitopes of immunoglobulin light chains, said hidden epitopes being epitopes that are hidden when a light chain is bound to a heavy chain and which are not available for binding to antibodies in a whole immunoglobulin, the method comprising:
A method of producing antibodies that are specific to hidden epitopes of immunoglobulin light chains, hidden epitopes being epitopes that are hidden when a light chain is bound to a heavy chain and which are not available for binding to antibodies in an intact immunoglobulin, the method comprising administering to an animal source of antibodies having an immune system intact IgG as a tolerogen and also administering to the animal antibodies specific to IgG Fc, wherein the antibodies specific to IgG Fc and the intact IgG are administered simultaneously or sequentially, and also immunising with free light chain, wherein the free light chain is administered simultaneously or sequentially with intact IgG tolerogen and antibodies to IgG Fc.
A method of producing antibodies that are specific to hidden epitopes of immunoglobulin light chains, said hidden epitopes being epitopes that are hidden when a light chain is bound to a heavy chain and which are not available for binding to antibodies in an intact immunoglobulin, the method comprising administering to animal intact IgG as a tolerogen and then administering to the animal antibodies specific to IgG Fc at the time of immunising the animal with free light chain.
A method of producing antibodies that are specific to hidden epitopes of immunoglobulin light chains, said hidden epitopes being epitopes that are hidden when a light chain is bound to a heavy chain and which are not available for binding to antibodies in an intact immunoglobulin, the method comprising administering to an animal intact IgG as a tolerogen and then administering to the animal antibodies specific to IgG Fc at the time of immunizing the animal with free light chain, and wherein the method further comprises using an animal which is naïve to the intact IgG administered as a tolerogen.
A method of producing antibodies that are specific to hidden determinants of immunoglobulin light chains, said hidden determinants being epitopes that are hidden when a light chain is bound to a heavy chain and which are not available for binding to antibodies in an intact immunoglobulin, the method comprising tolerising an antibody producing animal with immunoglobulin paraprotein having bound light chains and with antibodies to exposed determinants of the immunoglobulin paraprotein with bound light chains, with hidden determinants of the bound light chains not being available for binding to antibodies of the animal and immunizing the animal with free light chains of the immunoglobulin paraprotein, wherein the antibodies to exposed determinants of the immunoglobulin paraprotein with bound light chains are specific to an Fc region of the immunoglobulin.
A method of producing antibodies that are specific to hidden epitopes of immunoglobulin light chains, said hidden epitopes being epitopes that are hidden when a light chain is bound to a heavy chain and which are not available for binding to antibodies in an intact immunoglobulin, the method comprising, injecting an animal, as a source of antibodies, with free light chain, tolerizing with intact immunoglobulin and antibodies that bind only to parts of immunoglobulin that are not the hidden epitopes and that do not bind to said hidden epitopes of said light chains, wherein the antibodies that bind only to parts of immunoglobulin that are not the hidden epitopes and that do not bind to said hidden epitopes of said light chains are specific to an Fc region of the immunoglobulin.
A method of making antibodies specific for epitopes on free immunoglobulin light chains which are hidden and will not be available for binding in an intact immunoglobulin but are exposed on free immunoglobulin light chains comprising tolerising the immune system of a first non-human animal source of antibodies with immunoglobulin with bound immunoglobulin light chain and with antibodies to exposed epitopes of the immunoglobulin, wherein the antibodies to exposed epitopes of the immunoglobulin are specific to an Fc region of the immunoglobulin;
A method of making antibodies specific for determinants on free immunoglobulin light chains which are hidden and will not be available for binding in an intact immunoglobulin but are exposed on free immunoglobulin light chains, comprising tolerising an antibody-producing non-human animal with intact immunoglobulin with bound light chains and antibodies to the exposed determinants on the intact immunoglobulin, wherein the antibodies to the exposed determinants on the intact immunoglobulin are specific to an Fc region of the intact immunoglobulin;
A method of producing antibodies that are specific to hidden epitopes of immunoglobulin light chains, said hidden epitopes being epitopes that are hidden when a light chain is bound to a heavy chain and which are not available for binding to antibodies in a whole immunoglobulin, the method consisting of:
Dependencies are inferred from the claim text.